At the time of writing, Beamr Imaging Ltd [BMR] stock is trading at $2.81, down -3.44%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BMR shares have lost -9.94% over the last week, with a monthly amount drifted -7.57%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of Beamr Imaging Ltd fluctuated between $1.86 and $6.59. Beamr Imaging Ltd [NASDAQ: BMR] shares were valued at $2.81 at the most recent close of the market.
Analyzing the BMR fundamentals
According to Beamr Imaging Ltd [NASDAQ:BMR], the company’s sales were 3.13M for trailing twelve months, which represents an 6.69% jump. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -1.05%, Pretax Profit Margin comes in at -1.08%, and Net Profit Margin reading is -1.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.16 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.74 points at the first support level, and at 2.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.91, and for the 2nd resistance point, it is at 3.00.
Ratios To Look Out For
It is important to note that Beamr Imaging Ltd [NASDAQ:BMR] has a current ratio of 13.85. As well, the Quick Ratio is 13.85, while the Cash Ratio is 17.05. Considering the valuation of this stock, the price to sales ratio is 13.93, the price to book ratio is 2.39.
Transactions by insiders
Recent insider trading involved Disruptive Technologies III L., Shareholder, that happened on Aug 19 ’25 when 0.66 million shares were purchased. CHIEF EXECUTIVE OFFICER AND CH, SHARON CARMEL completed a deal on Dec 31 ’24 to buy 1.42 million shares.
